Trial Profile
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2014
Price :
$35
*
At a glance
- Drugs AZD 2423 (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Aug 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 10 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.